{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:56:06Z","timestamp":1781661366863,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.rcsop.2021.100060","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:27:04Z","timestamp":1628396824000},"page":"100060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An in-depth examination of funded and unfunded cognitive pharmaceutical services"],"prefix":"10.1016","volume":"3","author":[{"given":"Vivien","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Krass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2021.100060_bb0005","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.sapharm.2013.02.005","article-title":"Defining professional pharmacy services in community pharmacy","volume":"9","author":"Moullin","year":"2013","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2021.100060_bb0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.sapharm.2016.06.007","article-title":"Investigating influences on current community pharmacy practice at micro, meso, and macro levels","volume":"13","author":"Hermansyah","year":"2017","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2021.100060_bb0015","article-title":"The evolving profile of cognitive pharmaceutical services in Australia","author":"Tong","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2021.100060_bb0020","author":"Australian Government Department of Health and Ageing"},{"key":"10.1016\/j.rcsop.2021.100060_bb0025","author":"Australian Government Department of Health"},{"key":"10.1016\/j.rcsop.2021.100060_bb0030","author":"University of Technology Sydney"},{"key":"10.1016\/j.rcsop.2021.100060_bb0035","author":"University of Technology Sydney"},{"key":"10.1016\/j.rcsop.2021.100060_bb0040","author":"University of Technology Sydney"},{"key":"10.1016\/j.rcsop.2021.100060_bb0045","author":"University of Technology Sydney"},{"key":"10.1016\/j.rcsop.2021.100060_bb0050","author":"University of Technology Sydney"},{"key":"10.1016\/j.rcsop.2021.100060_bb0055","author":"University of Technology Sydney"},{"key":"10.1016\/j.rcsop.2021.100060_bb0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11096-012-9612-8","article-title":"Community pharmacists\u2019 perceptions of services that benefit older people in New Zealand","volume":"34","author":"Tordoff","year":"2012","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.rcsop.2021.100060_bb0065","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.sapharm.2012.11.003","article-title":"Community pharmacy in Australia: a health hub destination of the future","volume":"9","author":"McMillan","year":"2013","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2021.100060_bb0070","author":"Australian Government Department of Health"},{"key":"10.1016\/j.rcsop.2021.100060_bb0075","author":"Waterman P"},{"key":"10.1016\/j.rcsop.2021.100060_bb0080","author":"Consumers Health Forum of Australia"},{"key":"10.1016\/j.rcsop.2021.100060_bb0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.sapharm.2019.07.001","article-title":"A cross-sectional survey of enhanced and extended professional services in community pharmacies: a pharmacy perspective","volume":"16","author":"Sim TF","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2021.100060_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1609406917733847","article-title":"Thematic analysis: striving to meet the trustworthiness criteria","volume":"16","author":"Nowell","year":"2017","journal-title":"Int J Qual Methods"},{"key":"10.1016\/j.rcsop.2021.100060_bb0095","series-title":"Qualitative Data Analysis: An Expanded Sourcebook","author":"Miles","year":"1994"},{"key":"10.1016\/j.rcsop.2021.100060_bb0100","series-title":"Qualitative Methods for Health Research","author":"Green","year":"2014"},{"key":"10.1016\/j.rcsop.2021.100060_bb0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: an experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"key":"10.1016\/j.rcsop.2021.100060_bb0110","author":"The Pharmacy Guild of Australia"},{"key":"10.1016\/j.rcsop.2021.100060_bb0115","author":"Pharmaceutical Society of Australia"},{"key":"10.1016\/j.rcsop.2021.100060_bb0120","author":"The Pharmacy Guild of Australia"},{"key":"10.1016\/j.rcsop.2021.100060_bb0125","author":"The Pharmacy Guild of Australia"},{"key":"10.1016\/j.rcsop.2021.100060_bb0130","author":"The Pharmacy Guild of Australia"},{"key":"10.1016\/j.rcsop.2021.100060_bb0135","unstructured":"The Pharmacy Guild of Australia. Community Pharmacy Roadmap Program Development Template- Opioid Dependence Treatment. http:\/\/www.guild.org.au\/docs\/default-source\/public-documents\/tab---the-guild\/Strategic-Direction\/-opioid-dependence-treatment-programs.pdf?sfvrsn=0. (Accessed 04.12.20)."},{"key":"10.1016\/j.rcsop.2021.100060_bb0140","unstructured":"The Pharmacy Guild of Australia. Community Pharmacy Roadmap Program Development Template- Vaccine Administration. https:\/\/www.guild.org.au\/docs\/default-source\/public-documents\/tab---the-guild\/Strategic-Direction\/vaccine-administration.pdf?sfvrsn=0. (Accessed 04.12.20)."},{"key":"10.1016\/j.rcsop.2021.100060_bb0145","unstructured":"The Pharmacy Guild of Australia. Community Pharmacy Roadmap Program Development Template- Health Checks - Screening and Monitoring. https:\/\/www.guild.org.au\/docs\/default-source\/public-documents\/tab---the-guild\/Strategic-Direction\/health-checks-monitoring-screening.pdf?sfvrsn=0. (Accessed 04.12.20)."},{"key":"10.1016\/j.rcsop.2021.100060_bb0150","unstructured":"The Pharmacy Guild of Australia. Community Pharmacy Roadmap Program Development Template- Sleep Apnoea Support Services. https:\/\/www.guild.org.au\/docs\/default-source\/public-documents\/tab---the-guild\/Strategic-Direction\/sleep-apnoea-clinics.pdf?sfvrsn=0. (Accessed 04.12.20)."},{"key":"10.1016\/j.rcsop.2021.100060_bb0155","unstructured":"The Pharmacy Guild of Australia. Community Pharmacy Roadmap Program Development Template- Chronic Disease Management. http:\/\/www.guild.org.au\/docs\/default-source\/public-documents\/tab---the-guild\/Strategic-Direction\/chronic-disease-management.pdf?sfvrsn=0. (Accessed 04.12.20)."},{"key":"10.1016\/j.rcsop.2021.100060_bb0160","unstructured":"The Pharmacy Guild of Australia. Community Pharmacy Roadmap Program Development Template- Enhanced Compounding Services. http:\/\/www.guild.org.au\/docs\/default-source\/public-documents\/tab---the-guild\/Strategic-Direction\/compounding-services.pdf?sfvrsn=0. (Accessed 04.12.20)."},{"key":"10.1016\/j.rcsop.2021.100060_bb0165","author":"Pharmaceutical Society of Australia"},{"key":"10.1016\/j.rcsop.2021.100060_bb0170","author":"The Pharmacy Guild of Australia"},{"key":"10.1016\/j.rcsop.2021.100060_bb0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.sapharm.2020.05.007","article-title":"What free services do pharmacists offer? Investigating the provision of unfunded pharmacy services in community pharmacies","volume":"17","author":"Abdul Aziz","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2021.100060_bb0180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.hlc.2016.10.016","article-title":"Cardiovascular disease risk assessment in Australian community pharmacy","volume":"26","author":"McNamara","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.rcsop.2021.100060_bb0185","series-title":"Pharmacy: A Global Overview \u2013 Workforce, Medicines, Distribution, Practice, Regulation and Remuneration 2015\u20132017","author":"Pinto","year":"2017"},{"key":"10.1016\/j.rcsop.2021.100060_bb0190","author":"Pharmaceutical Society of Australia"},{"key":"10.1016\/j.rcsop.2021.100060_bb0195","author":"Pharmaceutical Society of Australia"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276621000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276621000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:28:42Z","timestamp":1757406522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276621000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":39,"alternative-id":["S2667276621000603"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2021.100060","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in-depth examination of funded and unfunded cognitive pharmaceutical services","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2021.100060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100060"}}